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Scientific integrity has always been a critical issue in
performing research. Recently, alarming signals from China
have reached the academic community in the USA and
Europe about scientific misconduct. One of the most
respected newspapers in our country (NRC Handelsblad,
11 December 2010) reported that at least one third of
leading scientists (2000 out of 6000) allied to one of the six
major Chinese Universities has been involved in scientific
misconduct such as plagiarism, data fabrication and data
manipulation. Not only in China, but in almost every
country, there are clear examples of scientific fraud in the
university setting [1].
Research misconduct may appear in many ways:
fabrication, falsification, plagiarism, manipulation, failure
to meet clear ethical and legal requirements, improper
dealing, and misdemeanors. Based on this phenomenon, a
European Code of Conduct for research integrity was put
forward in June 2010 by the European Science Foundation
(ESF). The ESF is an independent, non-governmental
organisation, the members of which are 79 national funding
agencies, research performing agencies, academies and
learned societies from 30 countries within Europe. The
European Code has been fully endorsed by the National
Organ for Scientific Integrity (LOWI), a Committee of the
Royal Dutch Academy of Arts and Sciences (KNAW,
www.knaw.nl)[ 2]. The principles of the Code include:
honesty in communication, reliability in performing research,
objectivity, impartiality and independence, openness and
accessibility, duty of care, fairness in providing references
and giving credit, and responsibility for the scientists and
researchers of the future. The European Code has installed
new guidelines for good research practice (GRP). They
include (1) data practices, (2) research procedures, (3)
responsibility, (4) publication-related conduct, and (5) editorial
responsibility.
With particular emphasis on GRP for scientific journals,
crucialissuessuchaspublication-relatedconductandeditorial
responsibility are more extensively described below. This
information was directly derived from the European Code of
Conduct for Research Integrity and can be found at www.esf.
org/activities/mo-fora/research-integrity.html
Publication Results should be published in an open,
transparent and accurate manner, at the earliest possible
time, unless intellectual property considerations justify
delay. All authors, unless otherwise specified, should be
fully responsible for the content of publication. Guest
authorship and ghost authorship are not acceptable. The
criteria for establishing the sequence of authors should be
agreed by all, ideally at the start of the project. Contributions
by collaborators and assistants should be acknowledged, with
their permission. All authors should declare any conflict of
interest. Intellectual contributions of others should be
acknowledged and correctly cited. Honesty and accuracy
should be maintained in communication with the public and
the popular media. Financial and other support for research
should be acknowledged.
Editorial Responsibility An editor or reviewer with a
potential conflict of interest should withdraw from involve-
ment with a given publication or disclose the conflict to the
readership. Reviewers should provide accurate, objective,
substantiated and justifiable assessments, and maintain
confidentiality. Reviewers should not, without permission,
make use of material in submitted manuscripts. Reviewers
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DOI 10.1007/s12471-010-0062-4who consider applications for funding, or applications by
individuals for appointment or promotion or other recognition,
should observe the same guidelines.
In cardiovascular medicine, the above-mentioned publi-
cation and editorial-conduct issues have been widely
recognised by both the Heart Editors Action Round Table
(HEART) group and the European Society of Cardiology
(ESC) through the Editors-in-Chief of the cardiovascular
journals belonging to the ESC National Societies. The
HEART Group (www.heartgroupjournals.org) consists of
the Editors-in-Chief of the major international cardiovascu-
lar journals and has produced a document (Statement on
Ethics) that addresses general ethical principles in the
conduct of the scientific process with which all of the
editors concur [3]. This Statement was simultaneously
published (2008) in all other major cardiovascular journals
including the Netherlands Heart Journal [4]. The HEART
Group is particularly alert to discovering scientific fraud
and data falsification, redundant or duplicate publication,
and plagiarism. Publishing ‘expression of concern’ notes or
even retraction of published material should be considered.
Salami slicing and shot gunning publication strategies have
to be strongly discouraged.
Within Europe, the ESC has established an Editor’s
Network of all National Society Cardiovascular Journals
(NSCJ). One of the major objectives of the Editor’sN e t w o r k
is to devise means to improve the scientific standards of the
NSCJ. Scientific content, quality requirements, credibility,
a n de d i t o r i a la n dr e s e a r c he t h i c sw i l lb ep r o m o t e d[ 5, 6]. To
further preserve scientific credibility, NSCJ editors should
harmonise their policies regarding scientific misconduct and
scientific fraud. Secondary publications, even in different
languages,shouldfollowthe requirements ofthe International
Committee of Medical Journal Editors (ICMJE). Both the
HEART Group and the ESC Editor’s Network mandate to
adhere to the ICMJE-edited ‘Uniform Requirements for
Manuscripts Submitted to Biomedical Journals: Writing and
Editing for Biomedical Publication’.
In October 2009, ICMJE developed an electronic
uniform disclosure form to avoid confusion for authors,
readers and the public. The creation of a uniform form was
based on the great variability in the processes that different
journals use to ask about and report authors’ potential
conflicts of interest. The new form is currently available on
the ICMJE website (www.icmje.org) and the websites of
the member journals. The glossary and instructions will be
available on the website in the next few months, and
translations will be posted on the ICMJE website as they
become available. The ICMJE will consider comments
received before 1 May 2011, when the next iteration of the
uniform conflict of interest disclosure form is prepared [7].
It is hoped that all scientific journals will adopt the new
2011 version of the uniform disclosure form in order to
prevent conflicts of interest and, more importantly, thereby
avoid scientific misconduct.
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